Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 27 for “"Epigenetic drugs"”.
-
Επιδράσεις επιγενετικών φαρμάκων στα CD3+ CD8+ κυτταρολυτικά κύτταρα ασθενών με καρκίνο
… This study aimed to investigate the effects of epigenetic drugs on antitumor peptide-specific CD8+ CTL clones isolated from patients with NSCLC and melanoma.MATERIALS AND METHODS: Three peptide-specific CD8+ CTL clones against hTERT and MAGE, isolated from patients with NSCLC and melanoma …
-
Modification of the epigenome as a potential therapy for breast cancer
… aimed to investigate the benefit of combining epigenetic drugs used at low concentrations to enhance the effects of DNA methyltransferase (DNMT) inhibitors against breast cancer cells, potentially broadening therapeutic options. Two treatments combining DNMT inhibitors with either histone …
-
Investigating the use of retinoids and epigenetic modification agents as new therapeutic strategies for the treatment of pancreatic cancer.
… by assessing the potential role of retinoids and epigenetic drugs both in vitro and in an animal model of PC. Aberrant retinoid signaling is associated with carcinogenesis, and has been identified in PC. The role of key retinoid signaling components implicated in retinoid resistance, CRBP1, RARα …
-
IDENTIFICATION OF G9A AS A THERAPEUTICALLY TARGETABLE DRIVER OF MULTIPLE MYELOMA TUMORIGENESIS
… hematological malignancy with highly disturbed epigenetic landscape. G9a, a histone methyltransferase, was found to promote disease progression, proliferation and metastasis via different mechanisms in several cancers, while the role of G9a in MM remains unknown. Here we show that G9a is …
-
Epigenetic regulation of keloid scarring
… keloid patients. Recent studies have shown that epigenetic modifications including DNA methylation, histone acetylation and non-coding RNAs all play major roles in keloid pathogenesis. Our lab has developed an epigenetic pathway small molecule inhibitor that can inhibit the CoREST repressor …
-
Genomic Analysis of Chemo-Resistance to HDAC inhibitor in Gastric Cancer cells
… (HDACis) are a promising class of anticancer epigenetic drugs, however, molecular factors influencing the responses of individual tumors to HDACi therapies remain obscure. Here, we sought to identify genes associated with HDACi resistance in gastric cancer. Treating a panel of 17 gastric …
-
Anti-ovarian cancer effects of histone deacetylase inhibitors and calpain inhibitor
… of the lack of sufficient target specific drugs. Typically, platinum in combination with other drugs is provided as the standard treatment. These combinations exhibit higher toxicity, are often not target specific, and frequently despite treatment, the tumor relapses. Current studies …
-
The epigenetic regulation of RIZ1 in human leukemia
… genetic phenomenon, however recent research into epigenetic causes of cancer emphasizes that these causes of cancer are also important. RIZ1 is a tumor suppressor which is silenced in many human leukemias, such as human Acute Myeloid Leukemia and Chronic Myelogenous Leukemia. It was the goal of …
-
Developing strategies to re-activate epigenetically silenced tumor suppressor genes in acute myeloid leukemia
Epigenetic mechanisms are essential for normal cell development. Alteration in those normal processes leads to malignant cell transformation and with this to cancer development. Use of inhibitors that alter the epigenetics of DNA methylation and histone post translational modifications has lead to …
-
Novel Micropatterned Substrate for Investigation of Ovarian Cancer Aggregate Formation and Response to Epigenetic Drug Therapy
… to better mimic in vivo response of tumors to drugs. This study will evaluate the feasibility of using a novel micropatterned substrate that enables 3D microenvironments for in vitro investigations of OvCa. The substrate was created through technologies used in integrated circuit fabrication …
-
The Epigenetics of Small Cell Prostate Cancer
… lineage programs should be reflected in distinct epigenetic profiles and that they could be reversed with epigenetic drugs. Using Methylated CpG Amplification coupled to Microarray (MCAM) we identified distinctly hypermethylated DNA sequences present in AR-SCPC but not in AR+ADENO xenografts. …
-
The FUS-DDIT3 interactome in myxoid liposarcoma
… suggests that FUS-DDIT3 may utilize a similar epigenetic mechanism of action, providing potential candidates for targeted therapy as epigenetic aberrations are potentially reversible by existing and emerging epigenetic drugs.
-
Role of UCHL1 in regulating gene expression in prostate cancer cells
… it is not expressed. However, treatment with the epigenetic drugs 5-aza-2′-deoxycytidine and trichostatin A (TSA) did not result in induction of UCHL1 expression in LNCaP, PC3 or C4-2 prostate cancer cell lines. UCHL1 is also associated with p53. However, ChIP assay results have shown that UCHL1 …
-
Epigenetic regulation of kidney cancer drug sensitivity, resistance, and fibrosis
This dissertation consists of studies on epigenetic regulation of kidney cancer drug sensitivity, resistance, and fibrosis. Epigenetics alterations are predominant causes of kidney cancer development but their roles in drug sensitivity, acquisition of drug resistance, and a pathological process …
-
Targeting Unique Domains of Lsd1 Regulates Pediatric Glioma Innate Immunity and Nk Cell Metabolism
… DNA template. Cancers will often hijack these epigenetic pathways, reactivating developmental genes to drive growth and deactivating tumor suppressor and immune recognition genes. Chromatin-modifying proteins deposit and remove chemical moieties from histone tails to aid in governing gene …
-
Interrogating the Epigenetic Determinants of State Heterogeneity in Adult Glioblastoma
… are complex, and include a large number of epigenetic and genetic factors. In this thesis, I explore glioblastoma heterogeneity in two distinct ways: I use single-cell chromatin accessibility data to explore influences of copy number alterations on the glioblastoma epigenome, and I apply …
-
Absence of p21 Expression Sensitizes iPSCs to iCaspase9 Induced Apoptosis While Not Impacting Ability to Participate in Exogenous Cartilage Repair
… with iCasp9. In addition to identifying several epigenetic drugs that promoted iCasp9 function in vitro, I also demonstrated that p21 inhibitors could phenocopy the enhanced iCasp9 mediate cell killing seen previously in the p21 mutant iPSCs. Overall, my findings indicate that p21 does play a …
-
Investigating the expression and function of aldehyde dehydrogenases in prostate cancer. Probing the expression and function of ALDHs using chemical probes, drugs and siRNA
… and LNCaP cells were sensitive to treatment with epigenetic drugs and led to significantly higher expression of ALDH1A2, ALDH3A1 and ALDH7A1 respectively. Importantly, siRNA suppression of ALDH1A3 and ALDH7A1 led to reduced SC properties of primary prostate cultures including reduced cell …
-
Investigating the expression and function of aldehyde dehydrogenases in prostate cancer. Probing the expression and function of ALDHs using chemical probes, drugs and siRNA
… and LNCaP cells were sensitive to treatment with epigenetic drugs and led to significantly higher expression of ALDH1A2, ALDH3A1 and ALDH7A1 respectively. Importantly, siRNA suppression of ALDH1A3 and ALDH7A1 led to reduced SC properties of primary prostate cultures including reduced cell …
-
Μελέτη μοριακών μηχανισμών αντικαρκινικής δράσης της σιλιμπινίνης (silibinin)
… with and regulate major components of the epigenetic machinery, often deregulated and implicated in the pathogenesis of Prostate Cancer (PCa). Silibinin possessed significant antiproliferative activity against prostate cancer cells DU-145 and PC-3, mediated in part by inhibition of cell …
Page 1 of 2